Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Effect of decreased endogenous betaglycan expression on metanephric development and glomerulogenesis. by Kenneth A. Walker (280683)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

(Related to Fig 2A). Comparison of mean percentages of transfected cells with SGs calculated from three biological triplicates, showing the decrease in %, as compared to the control (pEGF-N3-transfected cells, “GFP”). by Chiara Aloise (8374950)

Long-lived acceptor dark states can produce bimodal FRET efficiency distributions, multi-exponential donor excited-state decays, and a decrease in measured average FRET efficiency compared with that for the mean separation. by Steven S. Vogel (299330)

RNA Interference in <em>Schistosoma mansoni</em> Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening by Saša Štefanić (239531)

“…Transient RNAi has emerged as a straightforward and important technique to interrogate that information through decreased or loss of gene function and identify potential drug targets. …”

Percent accuracy and mean reaction time across the TLDB task. by David Apreutesei (19429483)

Deletion of TXNIP decreases nitrative stress under normoxia and hyperoxia. by Mohammed A. Abdelsaid (287140)

Mean coral cover versus bleaching susceptibility (η) for four IPCC climate-change scenarios (Commit, B1, A1b, and A1F1). by Peter J. Edmunds (208099)

“…<p>Smaller (larger) values of η correspond to decreased (increased) susceptibility to bleaching mortality. …”

Mean body weight. by Shane R. McClafferty (19434460)

Main parameters and meanings. by Tiaojuan Han (18196471)

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

“…</p><p>Methods</p><p>In an 8-week single-arm open-label pilot study of empagliflozin, we compared ambulatory glucose profiles produced from CGM data during 2-week intervals in a placebo run-in baseline period, end-of-treatment, and post-treatment. …”

Field evaluation of orange rust reaction and genotyping of molecular markers for the <i>G1</i> gene in a nuclear collection of 299 sugarcane accessions. by Gleicy Kelly Oliveira (19259604)

Subjects:

Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review by Weixin Wu (714474)

“…</p><p>Methods</p><p>We conducted a retrospective review of 333 patients with metastatic prostate cancer treated with docetaxel at a comprehensive cancer center between October 7, 2004 and December 31, 2012. …”

Intrathecal delivery of IL-6 increases cAMP and AC levels and decreases PDE level in the sensorimotor cortex. by Ping Yang (56755)

“…<p>Seven days after intrathecal delivery of IL-6, IL-6 and AG-490, or saline, cAMP, AC and PDE levels in the sensorimotor cortex were determined by ELISA. cAMP (A) and AC (C) levels increased while PDE (B) level decreased in IL-6 delivery group compared with that of saline group. …”

Effect of DM, and/or <i>M. charantia</i> on the immuno-expressional level of GFAP protein in maternal cerebellar tissue of different groups. by Amoura M. Abou-El-Naga (21001524)

BLB resistance assays for homozygous mutant rice lines L-5.7(-6), L-15.4(+1) and L-31.12(-3). by Phuong Nguyen Duy (11414117)

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Mean value of the longitudinal scaling exponent as a function of the growth rate threshold <i>b</i>_<i>c</i>. by Fabiano L. Ribeiro (4893388)

“…The mean value of decreases drastically as <i>b</i>_<i>c</i> increases. …”

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)